Nine Masts Capital LTD Bausch Health Companies Inc. Transaction History

Nine Masts Capital LTD

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 07, 2024	SELL	$6.1 - $10.41 $4.22 Million - $7.2 Million	-691,460 Reduced 79.07%	183,040 $1.28 Million
Q1 2024 May 08, 2024	BUY	$7.77 - $10.61 $6.79 Million - $9.28 Million	874,500 New	874,500 $9.28 Million
Q2 2019 Aug 08, 2019	SELL	$20.52 - $26.45 $62,073 - $80,011	-3,025 Closed	0 $0
Q1 2019 May 06, 2019	SELL	$20.23 - $26.29 $796,090 - $1.03 Million	-39,352 Reduced 92.86%	3,025 $75,000
Q4 2018 Feb 14, 2019	BUY	$17.64 - $28.32 $678,557 - $1.09 Million	38,467 Added 983.81%	42,377 $783,000
Q3 2018 Nov 16, 2018	BUY	$20.64 - $25.67 $80,702 - $100,369	3,910 New	3,910 $100,000

254

253M

5.53M

16.5M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $2.67B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Nine Masts Capital LTD, based on Form 13F filings with the SEC.

Stay updated on Nine Masts Capital LTD with notifications on news.